Search

everythinglearnresearchcommunity

for

Search:↓

Cutaneous calcinosis can be induced in young animals using certain compounds, but only in specific areas and with high mortality.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Combined therapy reduces inflammation and restores immune balance in alopecia areata patients.

Intralesional triamcinolone is more effective than topical betamethasone for treating localized alopecia areata.

Triamcinolone acetonide therapy for hair loss may cause a skin condition called linear lichen planus.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Oral pulse steroids reduce TNF-α levels, improving alopecia areata.

Intralesional vitamin D3 is an effective and safe treatment for patchy alopecia areata with fewer side effects.

Switching immunosuppressants can improve hair regrowth and well-being in transplant patients experiencing hair loss.

Microneedling with Triamcinolone acetonide is an effective, less invasive, and safe alternative to direct injections for treating alopecia areata.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Patients with GATA2 deficiency show early skin symptoms that help diagnose the condition.

Antituberculous drugs improved symptoms in a woman with lupus and myositis.

Testicular microlithiasis may increase the risk of testicular cancer and patients with it should be closely monitored.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

IL-17-producing γδ T cells help improve bone healing.

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.

Soft-tissue calcification is rare in systemic lupus erythematosus.

Methotrexate reduced the need for steroids in asthma patients without worsening their condition.

Giving dihydrotachysterol to mother rats caused skin hardening and bone issues in their babies through milk.

Tofacitinib helped improve symptoms and hair growth in a patient with Aicardi-Goutières syndrome.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

Smaller, diluted corticosteroid injections reduce the risk of vision loss.

The rash worsened due to a fungal infection masked by corticosteroids.

Alopecia areata is rare in organ transplant patients and may be linked to the drug tacrolimus.

Using cidofovir cream for a rare skin disease can cause skin darkening.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

DM and AA may share a common cause.